Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

The list for the next round of medicines that ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

The drug was administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD in the ENHANCE ... must surely now be on the hit-list of potential takeover targets.

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

Roche's strategic changes in drug development and M&A activity may drive future growth, despite recent setbacks in clinical ...

The people in India woke up this morning to the news and realisation that 2 cases of hMPV have been detected in Bengaluru’s Baptist hospital in infants between 3-8 months (detec ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...